CR20170233A - Anticuerpos anti-cd38 para el tratamiento de la leucemia mieloide aguda - Google Patents

Anticuerpos anti-cd38 para el tratamiento de la leucemia mieloide aguda

Info

Publication number
CR20170233A
CR20170233A CR20170233A CR20170233A CR20170233A CR 20170233 A CR20170233 A CR 20170233A CR 20170233 A CR20170233 A CR 20170233A CR 20170233 A CR20170233 A CR 20170233A CR 20170233 A CR20170233 A CR 20170233A
Authority
CR
Costa Rica
Prior art keywords
antibodies
treatment
myeloid leukemia
acute myeloid
methods
Prior art date
Application number
CR20170233A
Other languages
English (en)
Inventor
Santos Cedric Dos
Amy Sasser
Gwenn Danet-Desnoyers
Parul Doshi
Xiaochuan Shan
Original Assignee
Jannsen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jannsen Biotech Inc filed Critical Jannsen Biotech Inc
Priority claimed from PCT/US2015/063371 external-priority patent/WO2016089960A1/en
Publication of CR20170233A publication Critical patent/CR20170233A/es

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se refiere a métodos para el tratamiento de la leucemia mieloide aguda con anticuerpos anti-CD38.
CR20170233A 2014-12-04 2015-12-02 Anticuerpos anti-cd38 para el tratamiento de la leucemia mieloide aguda CR20170233A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462087422P 2014-12-04 2014-12-04
PCT/US2015/063371 WO2016089960A1 (en) 2014-12-04 2015-12-02 Anti-cd38 antibodies for treatment of acute myeloid leukemia

Publications (1)

Publication Number Publication Date
CR20170233A true CR20170233A (es) 2017-08-10

Family

ID=59927054

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20170233A CR20170233A (es) 2014-12-04 2015-12-02 Anticuerpos anti-cd38 para el tratamiento de la leucemia mieloide aguda

Country Status (1)

Country Link
CR (1) CR20170233A (es)

Similar Documents

Publication Publication Date Title
ECSP17042921A (es) Anticuerpos anti-cd38 para el tratamiento de la leucemia mieloide aguda
BR112016019871A2 (pt) anticorpos anti-cd38 para o tratamento de leucemia linfoblástica aguda
CL2021000630A1 (es) Métodos para producir un anticuerpo anti-c5 (divisional de la solicitud no. 201701585)
CY1122398T1 (el) Συνδυαστικες θεραπειες με αντισωματα anti-cd38
GEAP202114450A (en) Anti-tigit antibodies
CR20170086A (es) Terapias de combinación con anticuerpos anti-cd38
PH12016501763B1 (en) Multispecific antibodies
BR112017027724A2 (pt) terapias de combinação para malignidades hematológicas com anticorpos anti-cd38 e inibidores de survivina
MX2015010728A (es) Metodos y composiciones para el tratamiento de leucemia.
MX369857B (es) Pirazinas moduladoras de receptor 6 acoplado a la proteina g (gpr6).
AR101951A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
CR20170233A (es) Anticuerpos anti-cd38 para el tratamiento de la leucemia mieloide aguda
TH1401006967B (th) โครงสร้างการยึดติดสำหรับการยึดติดชิ้นส่วนสำหรับตกเเต่งของแผงหน้าปัด
TH1501007795A (th) หนังสังเคราะห์